2023
DOI: 10.1089/end.2022.0226
|View full text |Cite
|
Sign up to set email alerts
|

An Evaluation of Sexual Function in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia in Men Treated with the Temporarily Implanted Nitinol Device

Abstract: Purpose: To document the effect of the temporarily implanted nitinol device (iTind; Medi-Tate Ltd, Israel) on sexual function from a multicenter, randomized, single-blinded, sham-controlled trial. Materials and Methods: Men were randomized 2:1 between iTind and sham procedure arms. The iTind was placed for 5–7 days and an 18F Foley catheter was inserted and removed for the iTind and sham group, respectively. Patients were assessed at baseline, 3, and 12 months postopera… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
1
0
6

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 17 publications
0
1
0
6
Order By: Relevance
“…Mean scores for the IIEF and the Sexual Health Inventory for Males (SHIM) did not differ significantly from the baseline at 3 months. 50 Mean peak flow rate at 3 and 12 months was significantly improved ( P < .0001) from baseline in the TIPD group but was not reported for the SHAM group. There were few related serious adverse events but more overall adverse events within the first 30 days in the TIPD group than the SHAM group (38.1% versus 17.5%).…”
Section: Guideline Statement Updatesmentioning
confidence: 82%
“…Mean scores for the IIEF and the Sexual Health Inventory for Males (SHIM) did not differ significantly from the baseline at 3 months. 50 Mean peak flow rate at 3 and 12 months was significantly improved ( P < .0001) from baseline in the TIPD group but was not reported for the SHAM group. There were few related serious adverse events but more overall adverse events within the first 30 days in the TIPD group than the SHAM group (38.1% versus 17.5%).…”
Section: Guideline Statement Updatesmentioning
confidence: 82%
“…Zu Tind existiert eine prospektive Studie mit 1-und 3-Jahres-Follow-up [4,5]. Zu iTind wurde eine während 3 Monaten verblindete randomisierte Studie (iTind vs. Schein-OP) mit 1-Jahres-Follow-up publiziert [7,8]. Des Weiteren 2 multizentrische Fallserien: die MT 06- [9] und die MT-02-Studie, letztere mit 1-, 2-, 3-und 4-Jahres-Daten [6,10,11,12].…”
Section: Nicht-ablative Therapieverfahrenunclassified
“…Als Grad-3-Komplikationen nach Clavien-Dindo traten Harnverhalte (4,2-9,9%) und Makrohämaturie während der Implantation mit der Notwendigkeit einer operativen Blutstillung (1,4%) auf [7,9,11]. Eine retrograde De-novo-Ejakulations-oder Erektionsstörung wurde in keiner Studie beobachtet [6,7,8,9,10,11,12].…”
Section: Nicht-ablative Therapieverfahrenunclassified
See 2 more Smart Citations